Mei Kang
- Obstetrics and Gynecology top 10%
- Gestational Diabetes Research and Management 6
- Pregnancy and preeclampsia studies 3
- Ophthalmology top 10%
- Retinal Diseases and Treatments 2
-
- Diabetes Management and Research 2
-
- Esophageal Cancer Research and Treatment 11
- Esophageal and GI Pathology 4
-
- Gastric Cancer Management and Outcomes 6
- Lung Cancer Diagnosis and Treatment 3
Mei Kang
32 papers receiving 298 citations
Peers
Comparison fields: 5 of 59
- Obstetrics and Gynecology 52
- Ophthalmology 49
- Radiology, Nuclear Medicine and Imaging 86
- Endocrinology, Diabetes and Metabolism 43
- Surgery 94
Countries citing papers authored by Mei Kang
This map shows the geographic impact of Mei Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Kang more than expected).
Fields of papers citing papers by Mei Kang
This network shows the impact of papers produced by Mei Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Kang. The network helps show where Mei Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mei Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 20 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 23 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 24 | |
| 16 | 2020 | 20 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 13 | |
| 19 | 2018 | 10 | |
| 20 | 2018 | 9 |
About Mei Kang
Mei Kang is a scholar working on Obstetrics and Gynecology, Surgery and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 301 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (6 papers), Gestational Diabetes Research and Management (6 papers), Esophageal and GI Pathology (4 papers), Pregnancy and preeclampsia studies (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Retinal Diseases and Treatments (2 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Obstetrics and Gynecology (52 citations), Ophthalmology (49 citations) and Radiology, Nuclear Medicine and Imaging (86 citations). Mei Kang has collaborated with scholars based in China, Canada and Germany. Frequent co-authors include Yufan Wang, Mengyu Lai, Fang Fang, Xianming Xu, Yichun Wang, Na Li, Jingjing Huang, Yongde Peng, Liyang Zhu and Mingwei Yang. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.